These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29347975)

  • 21. The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial.
    Okebe J; Bousema T; Affara M; Di Tanna GL; Dabira E; Gaye A; Sanya-Isijola F; Badji H; Correa S; Nwakanma D; Van Geertruyden JP; Drakeley C; D'Alessandro U
    EBioMedicine; 2016 Nov; 13():348-355. PubMed ID: 27825738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose?
    Chen IT; Gosling RD
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):681-6. PubMed ID: 25118908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
    Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa.
    Chen I; Poirot E; Newman M; Kandula D; Shah R; Hwang J; Cohen JM; Gosling R; Rooney L
    Malar J; 2015 May; 14():204. PubMed ID: 25971688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.
    Shekalaghe S; Drakeley C; Gosling R; Ndaro A; van Meegeren M; Enevold A; Alifrangis M; Mosha F; Sauerwein R; Bousema T
    PLoS One; 2007 Oct; 2(10):e1023. PubMed ID: 17925871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
    Awandu SS; Raman J; Makhanthisa TI; Kruger P; Frean J; Bousema T; Niemand J; Birkholtz LM
    Malar J; 2018 Mar; 17(1):120. PubMed ID: 29558929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.
    Eziefula AC; Bousema T; Yeung S; Kamya M; Owaraganise A; Gabagaya G; Bradley J; Grignard L; Lanke KH; Wanzira H; Mpimbaza A; Nsobya S; White NJ; Webb EL; Staedke SG; Drakeley C
    Lancet Infect Dis; 2014 Feb; 14(2):130-9. PubMed ID: 24239324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
    Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ
    Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial.
    Raman J; Allen E; Workman L; Mabuza A; Swanepoel H; Malatje G; Frean J; Wiesner L; Barnes KI
    Malar J; 2019 Jun; 18(1):209. PubMed ID: 31234865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.
    White NJ; Qiao LG; Qi G; Luzzatto L
    Malar J; 2012 Dec; 11():418. PubMed ID: 23237606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
    Arango EM; Upegui YA; Carmona-Fonseca J
    Acta Trop; 2012 May; 122(2):177-82. PubMed ID: 22245668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
    Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
    Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primaquine: the risks and the benefits.
    Ashley EA; Recht J; White NJ
    Malar J; 2014 Nov; 13():418. PubMed ID: 25363455
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Pett H; Bradley J; Okebe J; Dicko A; Tiono AB; Gonçalves BP; Stone W; Chen I; Lanke K; Neuvonen M; Mustaniemi AL; Eziefula AC; Gosling R; D'Alessandro U; Drakeley C; Niemi M; Bousema T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant Efficacy of a Single Low Dose of Primaquine Compared to Stand-Alone Artemisinin Combination Therapy in Reducing Gametocyte Carriage in Cambodian Patients with Uncomplicated Multidrug-Resistant Plasmodium falciparum Malaria.
    Vantaux A; Kim S; Piv E; Chy S; Berne L; Khim N; Lek D; Siv S; Mukaka M; Taylor WR; Ménard D
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
    Valencia SH; Ocampo ID; Arce-Plata MI; Recht J; Arévalo-Herrera M
    Malar J; 2016 May; 15(1):291. PubMed ID: 27225440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
    Tine RC; Sylla K; Faye BT; Poirot E; Fall FB; Sow D; Wang D; Ndiaye M; Ndiaye JL; Faye B; Greenwood B; Gaye O; Milligan P
    Clin Infect Dis; 2017 Aug; 65(4):535-543. PubMed ID: 28605472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.
    Taylor WR; Hoglund RM; Peerawaranun P; Nguyen TN; Hien TT; Tarantola A; von Seidlein L; Tripura R; Peto TJ; Dondorp AM; Landier J; H Nosten F; Smithuis F; Phommasone K; Mayxay M; Kheang ST; Say C; Neeraj K; Rithea L; Dysoley L; Kheng S; Muth S; Roca-Feltrer A; Debackere M; Fairhurst RM; Song N; Buchy P; Menard D; White NJ; Tarning J; Mukaka M
    Malar J; 2021 Sep; 20(1):366. PubMed ID: 34503519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs.
    Wickham KS; Baresel PC; Marcsisin SR; Sousa J; Vuong CT; Reichard GA; Campo B; Tekwani BL; Walker LA; Rochford R
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5906-13. PubMed ID: 27458212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.